#efta01088037
LightNews LightNews
epsteinweb.bsky.social
EFTA01088037.jpg
#epsteinweb #efta01088037
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
EFTA01088033 | EFTA01088037 Table 3: Company NPVs by drug /LINN $11 $21 $24 $15 BIIB Tecfidera $78 Interferon $40 Tysabri $23 Others $38 CELG Revlimid $49 ThatNIdaza St Pomal s $9 $5 GILD HCV $43 HIV $40 Others $5 Eylea $244 $244 Praluent $39 $39 Dupilumab Sarilumab REGN widup and sari $22 $7 ALXN ALXN w!compelition Solids S125 $65 Strenslq $25 $25 Kanuma SI8 SI8 Na la $13 $49 $6 SO $42 $120 $162 74% Net cash ($2) Pipeline $94 Total $177 Price $271 % base biz 65% ($9) $44 $63 $107 59% Net cash $4 Pipeline S8 Total $92 Price $99 % base biz 92% Net cash S14 S14 Pipeline 5117 $88 Total $297 $326 Price $414 $414 % base biz 72% 79% Net cash ($8) ($8) Pipeline ($4) $58 Total $160 $100 Price $155 $155 % base biz 103% 64% $2 $34 S52 S86 60% BAIRN Alduraz me S5 VRTX Kal d $15 $58 $3 S7 $76 $83 91% Jakall $37 Baricitinib $20 Net cash $1 Pipeline $19 Total $58 Price $77 % base biz 75% INCY Source Sof/WNW 4naltictateessych Banker Amenca 4"3" Merrill Lynch S3 $29 Biotechnology 19 April 2016 $ EFTA01088037
May 9, 2026 at 1:32 AM